Cargando…
Direct and Label-Free Monitoring of Albumin in 2D Fatty Liver Disease Model Using Plasmonic Nanogratings
Non-alcoholic fatty liver (NAFLD) is a metabolic disorder related to a chronic lipid accumulation within the hepatocytes. This disease is the most common liver disorder worldwide, and it is estimated that it is present in up to 25% of the world’s population. However, the real prevalence of this dise...
Autores principales: | Lopez-Muñoz, Gerardo A., Ortega, Maria Alejandra, Ferret-Miñana, Ainhoa, De Chiara, Francesco, Ramón-Azcón, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765559/ https://www.ncbi.nlm.nih.gov/pubmed/33334062 http://dx.doi.org/10.3390/nano10122520 |
Ejemplares similares
-
Disposable Polymeric Nanostructured Plasmonic Biosensors for Cell Culture Adhesion Monitoring
por: Vila, Judith Camaló, et al.
Publicado: (2021) -
Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver
por: De Chiara, Francesco, et al.
Publicado: (2022) -
The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research
por: De Chiara, Francesco, et al.
Publicado: (2021) -
Plasmon-Enhanced Surface Photovoltage of ZnO/Ag Nanogratings
por: Gwon, Minji, et al.
Publicado: (2015) -
On-chip plasmonic spin-Hall nanograting for simultaneously detecting phase and polarization singularities
por: Feng, Fu, et al.
Publicado: (2020)